Skip to Main Content
×
Quiver Logo Get a Free Trial on Quiver Premium Today!
Back to News

Press Release: Schrier, Langworthy Introduce Bipartisan Bill to Expand Biosimilar Access

None

Bipartisan bill to streamline FDA biosimilar approvals and expand access to lower-cost prescription drugs.

Quiver AI Summary

Bill introduced: Reps. Kim Schrier and Nick Langworthy introduced the "Expedited Access to Biosimilars Act," a bipartisan proposal aimed at updating the FDA’s biosimilar approval process and reducing regulatory barriers. Supporters say it could help lower-cost prescription drugs reach patients sooner.

What the measure would do: The bill would clarify that extra clinical studies are not automatically required when existing evidence is sufficient, while keeping FDA authority to request more data when needed. It would also require earlier FDA notice to manufacturers if additional studies will be expected.

Supporters' case: The lawmakers said biosimilars can provide cheaper alternatives to biologic drugs, which are used to treat conditions such as cancer, arthritis, Crohn’s disease, diabetes and autoimmune disorders. The release says the proposal is backed by a coalition of healthcare, patient, insurer and industry groups.

Disclaimer: This is an AI-generated summary of a press release. The model used to summarize this release may make mistakes. See the full release here.

Check out the Quiver Quantitative API to build on top of data on congressional stock trading, insider transactions, hedge fund moves, and more.

🏛️ Receive Alerts on Congress
Sign Up

Kim Schrier Fundraising

Kim Schrier Fundraising

Kim Schrier recently disclosed $552.7K of fundraising in a Q1 FEC disclosure filed on April 15th, 2026. This was the 195th most from all Q1 reports we have seen this year. 67.6% came from individual donors.

Schrier disclosed $230.6K of spending. This was the 431st most from all Q1 reports we have seen from politicians so far this year.

Schrier disclosed $3.3M of cash on hand at the end of the filing period. This was the 125th most from all Q1 reports we have seen this year.

You can see the disclosure here, or track Kim Schrier's fundraising on Quiver Quantitative.

Kim Schrier Net Worth

Quiver Quantitative estimates that Kim Schrier is worth $20.0M, as of July 16th, 2026. This is the 65th highest net worth in Congress, per our live estimates.

Schrier has approximately $2.8M invested in publicly traded assets which Quiver is able to track live.

You can track Kim Schrier's net worth on Quiver Quantitative's politician page for Schrier.

Kim Schrier Bill Proposals

Here are some bills which have recently been proposed by Kim Schrier:

  • H.R.9445: To ensure the right to provide reproductive health care services, and for other purposes.
  • H.R.9000: SCREEN for Type 1 Diabetes Act of 2026
  • H.R.8425: Strengthening the Vaccines for Children Program Act of 2026
  • H.R.7712: RNGR Support Act of 2026
  • H.R.7377: Know Before You Drive Act
  • H.R.7164: Capping Costs for Consumers Act of 2026

You can track bills proposed by Kim Schrier on Quiver Quantitative's politician page for Schrier.

2026 Washington's 8th Congressional District Election

There has been approximately $5,628,890 of spending in Washington's 8th congressional district elections over the last two years, per our estimates.

Approximately $819,860 of this has been from outside spending by PACs and Super PACs. Some of the groups who are spending money in this race include:

The rating for this race is currently "Solid D".

You can track this election on our matchup page for the 2026 Washington's 8th congressional district election.

Add Quiver Quantitative to your preferred sources on Google Google News Logo

Suggested Articles